Core Viewpoint - The controlling shareholder of Langzi Co., Ltd., Shen Dongri, has pledged 20.77 million shares of the company due to personal funding needs, raising concerns about the company's financial stability and operational performance [2][4]. Share Pledge Details - Shen Dongri pledged 9.5 million shares to China International Capital Corporation and 11.27 million shares to CITIC Securities, with the pledge starting on January 27, 2026, for one year [2][3]. - The pledged shares represent 36.61% of Shen's total holdings and 17.5% of the company's total equity [4]. Financial Performance - Langzi Co., Ltd. expects a net profit of 900 million to 1.05 billion yuan for 2025, a year-on-year increase of 245.25% to 302.8%, primarily due to investments in the listed company Ruoyuchen [4]. - The company reported a revenue of 4.328 billion yuan for the first three quarters of 2025, remaining stable year-on-year, while the net profit excluding non-recurring items is projected to be between 220 million and 290 million yuan, reflecting a modest increase of 1.09% to 33.25% [5]. Business Segment Performance - The medical beauty segment generated approximately 2.237 billion yuan in revenue, a year-on-year increase of 2.49%, but the corresponding net profit decreased by 33.49% to 77.198 million yuan [6]. - The women's clothing segment achieved revenue of 1.407 billion yuan, with a slight net profit increase of 1.62% to 99.143 million yuan, while online sales grew by 22.55% [6]. - The infant and child segment reported revenue of 674 million yuan, with net profit declining significantly compared to the previous year [6]. Inventory and Financial Health - As of September 2025, the company's inventory for women's clothing reached approximately 630 million yuan, a 13.84% increase from the end of 2024, indicating rising inventory levels [6]. - The company faces financial pressure, with cash reserves of 505 million yuan insufficient to cover short-term borrowings of 1 billion yuan [10]. Strategic Moves - Langzi Co., Ltd. is accelerating its investment in the medical beauty sector, including a recent acquisition of a 67.5% stake in a cosmetic surgery hospital for 92.475 million yuan [7][8].
投资若羽臣赚了9.7亿元后 朗姿股份老板还在质押股票融资